|
Market Closed -
Nasdaq
01:30:00 22/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 7.690 USD | +2.40% |
|
+12.59% | -26.76% |
| 14/10 | Stifel Initiates Immatics at Buy With $15 Price Target | MT |
| 02/10 | Nanobiotix Names New Finance Chief | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 102.65Cr | - | ||||
| 6.63TCr | |||||
| 5.29TCr | |||||
| 5.48TCr | |||||
| 4.41TCr | |||||
| 4.37TCr |
- Stock Market
- Stocks
- IMTX Stock
- Charts Immatics N.V.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
